Detalles de la búsqueda
1.
A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant.
PLoS Pathog
; 18(4): e1010465, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35482816
2.
Elicitation of potent serum neutralizing antibody responses in rabbits by immunization with an HIV-1 clade C trimeric Env derived from an Indian elite neutralizer.
PLoS Pathog
; 17(4): e1008977, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33826683
3.
Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & omicron SARS-CoV-2 infection: Implications for boosting.
Indian J Med Res
; 157(6): 509-518, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37322634
4.
Neutralization diversity of HIV-1 Indian subtype C envelopes obtained from cross sectional and followed up individuals against broadly neutralizing monoclonal antibodies having distinct gp120 specificities.
Retrovirology
; 18(1): 12, 2021 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33990195
5.
Characterization of a stable HIV-1 B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes.
J Biol Chem
; 292(38): 15849-15858, 2017 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28743743
6.
Broad neutralization response in a subset of HIV-1 subtype C-infected viraemic non-progressors from southern India.
J Gen Virol
; 99(3): 379-392, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29458681
7.
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
J Virol
; 90(7): 3446-57, 2016 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-26763999
8.
Association of mutations in V3/C3 domain with enhanced sensitivity of HIV-1 clade C primary envelopes to autologous broadly neutralizing plasma antibodies.
Retrovirology
; 13(1): 41, 2016 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27307004
9.
HIV-1 clade C escapes broadly neutralizing autologous antibodies with N332 glycan specificity by distinct mechanisms.
Retrovirology
; 13(1): 60, 2016 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27576440
10.
Genetic attributes of blood-derived subtype-C HIV-1 tat and env in India and neurocognitive function.
J Med Virol
; 86(1): 88-96, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24150902
11.
Ancestral SARS-CoV-2-Driven Antibody Repertoire Diversity in an Unvaccinated Individual Correlates with Expanded Neutralization Breadth.
Microbiol Spectr
; : e0433222, 2023 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36946746
12.
Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses.
Lancet Infect Dis
; 22(4): 473-482, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34838183
13.
Geospatial HIV-1 subtype C gp120 sequence diversity and its predicted impact on broadly neutralizing antibody sensitivity.
PLoS One
; 16(5): e0251969, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34029329
14.
Effect of diversity in gp41 membrane proximal external region of primary HIV-1 Indian subtype C sequences on interaction with broadly neutralizing antibodies 4E10 and 10E8.
Virus Res
; 273: 197763, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31553924
15.
Broadly neutralizing antibodies in HIV-1 treatment and prevention.
Ther Adv Vaccines Immunother
; 6(4): 61-68, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30345419
16.
Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier category.
Virology
; 519: 99-105, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29684630
17.
Resultados
1 -
17
de 17
1
Próxima >
>>